Gomez-Almeria, M., Martínez-González, L., Matos, A. T., Rodriguez-Cueto, C., Vaz, A. R., Martín-Baquero, R., . . . Lago, E. d. (2026). Assessment of the therapeutic effect of IGS2.7, a CK1δ protein kinase inhibitor, in combination with riluzole for the treatment of ALS-associated TDP-43 proteinopathy.
Chicago Style CitationGomez-Almeria, Marta, et al. Assessment of the Therapeutic Effect of IGS2.7, a CK1δ Protein Kinase Inhibitor, in Combination With Riluzole for the Treatment of ALS-associated TDP-43 Proteinopathy. 2026.
MLA CitationGomez-Almeria, Marta, et al. Assessment of the Therapeutic Effect of IGS2.7, a CK1δ Protein Kinase Inhibitor, in Combination With Riluzole for the Treatment of ALS-associated TDP-43 Proteinopathy. 2026.
Warning: These citations may not always be 100% accurate.